Cargando…

Inclusion body myositis – pathomechanism and lessons from genetics

Inclusion body myositis is a rare, late-onset myopathy. Both inflammatory and myodegenerative features play an important role in their pathogenesis. Overlapping clinicopathological entities are the familial inclusion body myopathies with or without dementia. These myopathies share several clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murnyák, Balázs, Bodoki, Levente, Vincze, Melinda, Griger, Zoltán, Csonka, Tamás, Szepesi, Rita, Kurucz, Andrea, Dankó, Katalin, Hortobágyi, Tibor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2015
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152972/ https://www.ncbi.nlm.nih.gov/pubmed/28352694 http://dx.doi.org/10.1515/med-2015-0030

Ejemplares similares

Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort
por: András, Csilla, et al.
Publicado: (2019)

Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort
por: Szabó, Katalin, et al.
Publicado: (2022)

Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort
por: Szabó, Katalin, et al.
Publicado: (2018)

Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis
por: Zilahi, Erika, et al.
Publicado: (2019)

The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center
por: Vincze, Anett, et al.
Publicado: (2020)

Vitamin D Receptor Gene Polymorphisms and Haplotypes in Hungarian Patients with Idiopathic Inflammatory Myopathy
por: Bodoki, Levente, et al.
Publicado: (2015)

Immune and myodegenerative pathomechanisms in inclusion body myositis
por: Keller, Christian W., et al.
Publicado: (2017)

Pruritogenic molecules in the skin of patients with dermatomyositis
por: Vincze, Anett, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA-Induced Early Onco/Suppressor Gene Expression with Tissue-Specificity in Mice
por: Gergely, Péter Attila, et al.
Publicado: (2019)

Immunohistochemical correlates of TP53 somatic mutations in cancer
por: Murnyák, Balázs, et al.
Publicado: (2016)

Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing
por: Hedberg‐Oldfors, Carola, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis and delayed onset muscle soreness in light of the impaired blink and stretch reflexes – watch out for Piezo2
por: Sonkodi, Balázs, et al.
Publicado: (2022)

Infective myositis
por: Narayanappa, Gayathri, et al.
Publicado: (2021)

Epigenetics of Meningiomas
por: Murnyák, Balázs, et al.
Publicado: (2015)

Is the Sex Difference a Clue to the Pathomechanism of Dry Eye Disease? Watch out for the NGF-TrkA-Piezo2 Signaling Axis and the Piezo2 Channelopathy
por: Sonkodi, Balázs, et al.
Publicado: (2022)

The Melanin-concentrating Hormone System in Human, Rodent and Avian Brain
por: Bencze, János, et al.
Publicado: (2018)

Silent hypoxia in COVID-19: pathomechanism and possible management strategy
por: Rahman, Ahsab, et al.
Publicado: (2021)

Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study
por: Péter, Andrea, et al.
Publicado: (2022)

New Prognostic Score for the Prediction of 30-Day Outcome in Spontaneous Supratentorial Cerebral Haemorrhage
por: Szepesi, Rita, et al.
Publicado: (2015)

Neural adaptations to electrical stimulation strength training
por: Hortobágyi, Tibor, et al.
Publicado: (2011)

Pathophysiology of Meningioma Growth in Pregnancy
por: Hortobágyi, Tibor, et al.
Publicado: (2017)

The role of interferons type I, II and III in myositis: A review
por: Bolko, Loïs, et al.
Publicado: (2021)

Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management
por: Vincze, Anett, et al.
Publicado: (2021)

Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
por: Betteridge, Z., et al.
Publicado: (2019)

The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort
por: Edigin, Ehizogie, et al.
Publicado: (2020)

Detecting dysphagia in inclusion body myositis
por: Cox, F. M., et al.
Publicado: (2009)

Inclusion Body Myositis Treated with Alemtuzumab
por: Sá, Juliana, et al.
Publicado: (2019)

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Inclusion body myositis--a case report.
por: Park, S. H., et al.
Publicado: (1996)

Inclusion-Body Myositis Associated with Alzheimer's Disease
por: Levacic, Danijela, et al.
Publicado: (2013)

Inclusion body myositis associated with Sjögren’s syndrome
por: Misterska-Skóra, Maria, et al.
Publicado: (2012)

Proteomic study of sporadic inclusion body myositis
por: Li, Ke, et al.
Publicado: (2014)

Ongoing Developments in Sporadic Inclusion Body Myositis
por: Machado, Pedro M., et al.
Publicado: (2014)

17. Inclusion body myositis associated with SLE
por: Jones, Catrin M, et al.
Publicado: (2018)

Survival and associated comorbidities in inclusion body myositis
por: Naddaf, Elie, et al.
Publicado: (2021)

Dysphagia as the Presenting Symptom for Inclusion Body Myositis
por: Esteban, Marcus Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73d21sef37jmk0s23rsq5te4eh